Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Paraskevi Apostolou"'
Autor:
Paraskevi Apostolou, Vasiliki Dellatola, Athanasios Papathanasiou, Despoina Kalfakakou, Elena Fountzilas, Dimitrios Tryfonopoulos, Sofia Karageorgopoulou, Drakoulis Yannoukakos, Irene Konstantopoulou, Florentia Fostira
Publikováno v:
Cancers, Vol 16, Iss 13, p 2368 (2024)
Early-onset breast cancer constitutes a major criterion for genetic testing referral. Nevertheless, studies focusing on breast cancer patients (≤30 years) are limited. We investigated the contribution and spectrum of known breast-cancer-associated
Externí odkaz:
https://doaj.org/article/dcf086bdce2c42ffba42baca7db8d0b4
Autor:
Paraskevi Apostolou, Vasiliki Dellatola, Christos Papadimitriou, Despoina Kalfakakou, Elena Fountzilas, Eleni Faliakou, Georgios Fountzilas, Ourania Romanidou, Irene Konstantopoulou, Florentia Fostira
Publikováno v:
Cancers, Vol 13, Iss 9, p 2106 (2021)
CHEK2 germline pathogenic variants predispose to breast cancer and possibly to other malignancies, with their spectrum and frequency being variable among populations. Τhe majority of CHEK2-associated breast tumors are hormone receptor positive; howe
Externí odkaz:
https://doaj.org/article/7a54c7e0d6ff49c48451cb637c0ea007
Autor:
Ourania Romanidou, Paraskevi Apostolou, Kyriakos Kouvelakis, Kyriakos Tsangaras, Alexia Eliades, Achilleas Achilleos, Charalambos Loizides, Christos Lemesios, Marios Ioannides, Elena Kypri, George Koumbaris, Kyriaki Papadopoulou, Athanasios Papathanasiou, Georgios Rigakos, Ioannis Xanthakis, Florentia Fostira, Vassiliki Kotoula, George Fountzilas, Philippos Patsalis
Publikováno v:
Oncol Lett
Gliomas are the most common malignant primary brain tumors characterized by poor prognosis. The genotyping of tumors using next generation sequencing (NGS) platforms enables the identification of genetic alterations that constitute diagnostic, progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca29322205c134cd198ebfb1e03b5f1
https://europepmc.org/articles/PMC9773316/
https://europepmc.org/articles/PMC9773316/
Autor:
Elena Fountzilas, Paraskevi Apostolou, Angelo V. Vasiliadis, Dimitra Aivazi, Emmanouil Saloustros, Florentia Fostira
Publikováno v:
Familial Cancer. 21:479-487
Genetic testing has been implemented in clinical practice. However, data on physician's practices and education related to cancer genetics, risk assessment and clinical management in Greece, is limited. In Greece, genetic counseling is performed by t
Autor:
Spyros Miliaras, Konstantinos Papazisis, George Fountzilas, Sofia Chrisafi, Eleni Vrettou, Thomas Zaramboukas, Ioannis Natsiopoulos, Georgia-Angeliki Koliou, Ioannis Tikas, Efterpi Demiri, Anthoula Asimaki-Vlachopoulou, Elena Fountzilas, Florentia Fostira, Kyriaki Papadopoulou, Christos Poulios, Ananias Ananiadis, Paraskevi Apostolou, Vassiliki Kotoula, Aris P. Tsiftsoglou
Publikováno v:
Breast Cancer. 28:1367-1382
The genomic status of non-malignant tissues from carriers of pathogenic germline BRCA1/2 (gBRCA1/2) variants may reveal information towards individualized prophylaxis. We performed spatiotemporal tissue genotype comparisons in a real-life cohort of g
Autor:
Florentia Fostira, Dimitrios Nasikas, Paraskevi Apostolou, Vassiliki Dellatola, Anna Fokianou, Panagiota Kontogianni, Romina Alevizou, Sofia Filippidou, Dimitrios Maniatis, Lazaros Papadopoulos, Emmanouil Pavlakis, Panagiota Ntasiou, Sofia Karageorgopoulou, Grigorios Xepapadakis
Publikováno v:
Cancer Research. 83:P6-02
Background. Carcinoma in situ (CIS) of the breast is a non-obligatory pre-malignant breast lesion and a highly suspected precursor of invasive cancer. Although the selection criteria for referral to genetic testing are well established for patients d
Autor:
Kyriaki Manousou, Angeliki Delimitsou, Paraskevi Apostolou, G. Fountzilas, Drakoulis Yannoukakos, Christos Christodoulou, Florentia Fostira, Andromahi Vagena, Christos Papadimitriou, Dimitrios Tryfonopoulos, Irene Konstantopoulou, Elena Fountzilas, Myrto Papamentzelopoulou
Publikováno v:
Clinical Breast Cancer. 20:152-159
BRCA1/BRCA2 mutation carriers indefinitely comprise a distinct group of patients with breast cancer (BC), with their tumors displaying specific pathologic characteristics. Although these connections are known, they are not fully elucidated. We theref
Autor:
Drakoulis Yannoukakos, Despoina Kalfakakou, Nikolaos Androulakis, Paraskevi Apostolou, Sofia Agelaki, Elias Sanidas, Antonia Kalykaki, Christos Papadimitriou, Vassilis Georgoulias, Konstantinos Kalbakis, Lambros Vamvakas, Christos Christodoulou, Charalambos Kouroussis, Dimitris Mavroudis, Florentia Fostira, Irene Konstantopoulou, Angeliki Delimitsou, Emmanouil Saloustros
Publikováno v:
International Journal of Cancer. 147:1334-1342
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, the BRCA1/2 variant spect
Autor:
Irene Konstantopoulou, Dimitris Loutradis, Constantine Dimitrakakis, Florentia Fostira, Myrto Papamentzelopoulou, George Fountzilas, Drakoulis Yannoukakos, Paraskevi Apostolou
Publikováno v:
Cancer Genetics. 237:90-96
Purpose Multiple lines of evidence have suggested a likely causative role in breast/ovarian cancer (BrCa/OvCa) predisposition for the BRCA1 p.(Val1833Met) variant, predominantly found among Greek patients. Our aim was to study the variant's prevalenc
Autor:
Paraskevi Apostolou
Ο καρκίνος του μαστού αποτελεί τον πιο συνηθισμένο τύπο καρκίνου που διαγιγνώσκεται στις γυναίκες στις ανεπτυγμένες χώρες. Περίπου 5-10%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03d5f61c75cd5b427e4d4e59895d3877
https://doi.org/10.12681/eadd/39184
https://doi.org/10.12681/eadd/39184